Drug profile · INN
clindamycin hydrochloride
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride (CLINDAMYCIN HYDROCHLORIDE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — clindamycin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
clindamycin hydrochloride (CLINDAMYCIN HYDROCHLORIDE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clindamycin hydrochloride?
clindamycin hydrochloride (CLINDAMYCIN HYDROCHLORIDE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clindamycin hydrochloride?
CLINDAMYCIN HYDROCHLORIDE is a marketed brand name for clindamycin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clindamycin hydrochloride?
clindamycin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.